Annual Working Capital
-$4.46 B
-$2.62 B-142.87%
31 December 2023
Summary:
Novo Nordisk A/S annual working capital is currently -$4.46 billion, with the most recent change of -$2.62 billion (-142.87%) on 31 December 2023. During the last 3 years, it has fallen by -$3.72 billion (-503.86%). NVO annual working capital is now -220.33% below its all-time high of $3.70 billion, reached on 31 December 2009.NVO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
-$1.98 B
-$482.59 M-32.30%
30 September 2024
Summary:
Novo Nordisk A/S quarterly working capital is currently -$1.98 billion, with the most recent change of -$482.59 million (-32.30%) on 30 September 2024. Over the past year, it has increased by +$2.32 billion (+54.02%). NVO quarterly working capital is now -152.85% below its all-time high of $3.74 billion, reached on 30 June 2011.NVO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -142.9% | +54.0% |
| 3 y3 years | -503.9% | -539.2% |
| 5 y5 years | -693.2% | -4409.9% |
NVO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -503.9% | at low | -539.2% | +72.2% |
| 5 y | 5 years | -693.2% | at low | -308.2% | +72.2% |
| alltime | all time | -220.3% | at low | -152.8% | +72.2% |
Novo Nordisk A/S Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.98 B(+32.3%) |
| June 2024 | - | -$1.49 B(-79.0%) |
| Mar 2024 | - | -$7.11 B(+59.7%) |
| Dec 2023 | -$4.46 B(+142.9%) | -$4.46 B(+3.6%) |
| Sept 2023 | - | -$4.30 B(+54.5%) |
| June 2023 | - | -$2.78 B(+5.5%) |
| Mar 2023 | - | -$2.64 B(+43.8%) |
| Dec 2022 | -$1.83 B(-13.4%) | -$1.83 B(+28.8%) |
| Sept 2022 | - | -$1.42 B(+51.9%) |
| June 2022 | - | -$937.30 M(-31.1%) |
| Mar 2022 | - | -$1.36 B(-35.8%) |
| Dec 2021 | -$2.12 B(+187.2%) | -$2.12 B(-570.9%) |
| Sept 2021 | - | $450.09 M(-35.3%) |
| June 2021 | - | $695.81 M(-140.2%) |
| Mar 2021 | - | -$1.73 B(+134.9%) |
| Dec 2020 | -$737.83 M(-241.7%) | -$737.83 M(-272.1%) |
| Sept 2020 | - | $428.72 M(-54.9%) |
| June 2020 | - | $949.63 M(>+9900.0%) |
| Mar 2020 | - | $886.10 K(-99.8%) |
| Dec 2019 | $520.68 M(-30.7%) | $520.68 M(+1035.2%) |
| Sept 2019 | - | $45.87 M(-85.8%) |
| June 2019 | - | $323.73 M(-206.3%) |
| Mar 2019 | - | -$304.47 M(-140.5%) |
| Dec 2018 | $751.09 M(-64.2%) | $751.09 M(+2.5%) |
| Sept 2018 | - | $732.83 M(-43.2%) |
| June 2018 | - | $1.29 B(+35.9%) |
| Mar 2018 | - | $950.09 M(-54.7%) |
| Dec 2017 | $2.10 B(+19.7%) | $2.10 B(+10.8%) |
| Sept 2017 | - | $1.89 B(-18.7%) |
| June 2017 | - | $2.33 B(+140.5%) |
| Mar 2017 | - | $968.92 M(-44.7%) |
| Dec 2016 | $1.75 B(-16.1%) | $1.75 B(+16.7%) |
| Sept 2016 | - | $1.50 B(-9.4%) |
| June 2016 | - | $1.66 B(+105.7%) |
| Mar 2016 | - | $806.88 M(-61.4%) |
| Dec 2015 | $2.09 B(+1.6%) | $2.09 B(+6.9%) |
| Sept 2015 | - | $1.96 B(+48.8%) |
| June 2015 | - | $1.31 B(+516.0%) |
| Mar 2015 | - | $213.40 M(-89.6%) |
| Dec 2014 | $2.06 B(-37.7%) | $2.06 B(+8.4%) |
| Sept 2014 | - | $1.90 B(-0.8%) |
| June 2014 | - | $1.91 B(+28.3%) |
| Mar 2014 | - | $1.49 B(-54.8%) |
| Dec 2013 | $3.30 B(+0.5%) | $3.30 B(+19.6%) |
| Sept 2013 | - | $2.76 B(+42.2%) |
| June 2013 | - | $1.94 B(+11.0%) |
| Mar 2013 | - | $1.75 B(-46.7%) |
| Dec 2012 | $3.28 B(+0.2%) | $3.28 B(+29.3%) |
| Sept 2012 | - | $2.54 B(+25.8%) |
| June 2012 | - | $2.02 B(-21.4%) |
| Mar 2012 | - | $2.57 B(-21.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $3.28 B(-2.3%) | $3.28 B(-2.6%) |
| Sept 2011 | - | $3.37 B(-10.0%) |
| June 2011 | - | $3.74 B(+14.8%) |
| Mar 2011 | - | $3.26 B(-2.9%) |
| Dec 2010 | $3.36 B(-9.3%) | $3.36 B(+8.1%) |
| Sept 2010 | - | $3.11 B(+22.2%) |
| June 2010 | - | $2.54 B(-11.6%) |
| Mar 2010 | - | $2.88 B(-22.3%) |
| Dec 2009 | $3.70 B(+22.2%) | $3.70 B(+4.1%) |
| Sept 2009 | - | $3.56 B(+9.4%) |
| June 2009 | - | $3.25 B(+26.0%) |
| Mar 2009 | - | $2.58 B(-14.8%) |
| Dec 2008 | $3.03 B(+13.3%) | $3.03 B(+8.3%) |
| Sept 2008 | - | $2.80 B(-12.8%) |
| June 2008 | - | $3.21 B(+15.7%) |
| Mar 2008 | - | $2.78 B(+3.8%) |
| Dec 2007 | $2.67 B(+41.6%) | $2.67 B(+11.9%) |
| Sept 2007 | - | $2.39 B(+6.2%) |
| June 2007 | - | $2.25 B(+22.3%) |
| Mar 2007 | - | $1.84 B(-2.5%) |
| Dec 2006 | $1.89 B(+32.8%) | $1.89 B(+23.1%) |
| Sept 2006 | - | $1.54 B(-11.1%) |
| June 2006 | - | $1.73 B(+27.3%) |
| Mar 2006 | - | $1.36 B(-4.6%) |
| Dec 2005 | $1.42 B(-25.9%) | $1.42 B(-0.2%) |
| Sept 2005 | - | $1.42 B(+12.7%) |
| June 2005 | - | $1.26 B(-18.2%) |
| Mar 2005 | - | $1.55 B(-19.4%) |
| Dec 2004 | $1.92 B(+17.5%) | $1.92 B(+24.0%) |
| Sept 2004 | - | $1.55 B(+6.4%) |
| June 2004 | - | $1.45 B(+6.6%) |
| Mar 2004 | - | $1.36 B(-16.5%) |
| Dec 2003 | $1.63 B(+48.5%) | $1.63 B(+48.5%) |
| Dec 2002 | $1.10 B(+18.5%) | $1.10 B(+18.5%) |
| Dec 2001 | $928.65 M(+21.9%) | $928.65 M(+21.9%) |
| Dec 2000 | $762.06 M(-17.9%) | $762.06 M(-17.9%) |
| Dec 1999 | $927.97 M(-21.8%) | $927.97 M(-21.8%) |
| Dec 1998 | $1.19 B(+7.5%) | $1.19 B(+7.5%) |
| Dec 1997 | $1.10 B(+7.9%) | $1.10 B(+7.9%) |
| Dec 1996 | $1.02 B(-0.3%) | $1.02 B(-0.3%) |
| Dec 1995 | $1.03 B(-27.6%) | $1.03 B(-27.6%) |
| Dec 1994 | $1.42 B(+74.2%) | $1.42 B(+74.2%) |
| Dec 1993 | $813.89 M(-28.8%) | $813.89 M(-28.8%) |
| Dec 1992 | $1.14 B(+46.0%) | $1.14 B(+46.0%) |
| Dec 1991 | $783.22 M(+83.4%) | $783.22 M(+83.4%) |
| Dec 1990 | $427.06 M(+2.9%) | $427.06 M(+2.9%) |
| Dec 1989 | $415.11 M(+32.0%) | $415.11 M(+32.0%) |
| Dec 1988 | $314.45 M(-7.5%) | $314.45 M(-7.5%) |
| Dec 1987 | $339.96 M(+16.1%) | $339.96 M(+16.1%) |
| Dec 1986 | $292.90 M(-2.2%) | $292.90 M(-2.2%) |
| Dec 1985 | $299.51 M(+37.9%) | $299.51 M(+37.9%) |
| Dec 1984 | $217.20 M | $217.20 M |
FAQ
- What is Novo Nordisk A/S annual working capital?
- What is the all time high annual working capital for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual working capital year-on-year change?
- What is Novo Nordisk A/S quarterly working capital?
- What is the all time high quarterly working capital for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly working capital year-on-year change?
What is Novo Nordisk A/S annual working capital?
The current annual working capital of NVO is -$4.46 B
What is the all time high annual working capital for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual working capital is $3.70 B
What is Novo Nordisk A/S annual working capital year-on-year change?
Over the past year, NVO annual working capital has changed by -$2.62 B (-142.87%)
What is Novo Nordisk A/S quarterly working capital?
The current quarterly working capital of NVO is -$1.98 B
What is the all time high quarterly working capital for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly working capital is $3.74 B
What is Novo Nordisk A/S quarterly working capital year-on-year change?
Over the past year, NVO quarterly working capital has changed by +$2.32 B (+54.02%)